- Home
- APPS vs TSVT Comparison
APPS vs TSVT Comparison
Compare APPS & TSVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APPS
- TSVT
- Stock Information
- Founded
- APPS 2007
- TSVT 2021
- Country
- APPS United States
- TSVT United States
- Employees
- APPS N/A
- TSVT N/A
- Industry
- APPS Multi-Sector Companies
- TSVT Biotechnology: Pharmaceutical Preparations
- Sector
- APPS Miscellaneous
- TSVT Health Care
- Exchange
- APPS Nasdaq
- TSVT Nasdaq
- Market Cap
- APPS 243.8M
- TSVT 258.9M
- IPO Year
- APPS N/A
- TSVT N/A
- Fundamental
- Price
- APPS $3.12
- TSVT $4.98
- Analyst Decision
- APPS Hold
- TSVT Buy
- Analyst Count
- APPS 4
- TSVT 4
- Target Price
- APPS $2.38
- TSVT $6.50
- AVG Volume (30 Days)
- APPS 3.3M
- TSVT 1.1M
- Earning Date
- APPS 05-27-2025
- TSVT 05-07-2025
- Dividend Yield
- APPS N/A
- TSVT N/A
- EPS Growth
- APPS N/A
- TSVT N/A
- EPS
- APPS N/A
- TSVT N/A
- Revenue
- APPS $483,577,000.00
- TSVT $37,862,000.00
- Revenue This Year
- APPS N/A
- TSVT $84.48
- Revenue Next Year
- APPS $6.49
- TSVT $9.69
- P/E Ratio
- APPS N/A
- TSVT N/A
- Revenue Growth
- APPS N/A
- TSVT N/A
- 52 Week Low
- APPS $1.18
- TSVT $2.29
- 52 Week High
- APPS $6.86
- TSVT $5.30
- Technical
- Relative Strength Index (RSI)
- APPS 53.23
- TSVT 76.79
- Support Level
- APPS $3.24
- TSVT $4.88
- Resistance Level
- APPS $2.85
- TSVT $4.99
- Average True Range (ATR)
- APPS 0.35
- TSVT 0.03
- MACD
- APPS 0.06
- TSVT -0.08
- Stochastic Oscillator
- APPS 94.39
- TSVT 90.91
About APPS Digital Turbine Inc.
Digital Turbine Inc is an independent mobile growth platform. It offers end-to-end products and solutions to all participants in the mobile application ecosystem, enabling brand discovery and advertising, user acquisition and engagement, and operational efficiency for advertisers. Its operating segments are On Device Solutions and App Growth Platform.
About TSVT 2seventy bio Inc.
2seventy bio Inc is a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer. The company operates in a single segment, focusing on researching, developing and commercializing potentially transformative treatments for cancer.